3177 results for «391»
3177 results
Next-gen complex interventional techniques and solutions
21 Sep 2023 – From AICT-AsiaPCR 2023
Join us in this session where experts delve into advanced techniques for complex interventions: discover tips for PCI without metallic stents, explore novel tools for bifurcation and complex lesions, and learn from clinical experiences in managing long diffused lesions.
Learning - Cardiogenic shock
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore the complexities of cardiogenic shock management in this session: understand its pathophysiology, learn about the role of mechanical support (IABP, Impella, ECMO) in addition to pharmacological treatment, gather tips and tricks from expert speakers and gain insights into real-world cases.
Other valvular interventions
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore innovative approaches to various valvular interventions in this session: from managing post-mitral valve replacement complications and performing balloon mitral valvotomy in patients with restenosis after mitral valve interventions to tackling calcified mitral valves and addressing unique cases like LBB pacing in isolated ccTGA with complete...
Advanced approaches to treating calcified lesions
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover advanced insights into calcified lesions in this session, covering topics such as: managing double disasters, treating severe calcified left main disease, addressing complications in double vessel rotablation with left main bifurcation stenting, and using rotatripsy in OCT-guided PCI for calcified left anterior descending artery.
How to manage complications in CTO PCI
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore complex CTO PCI scenarios and gain insights into complications and their solutions in this session. Topics include CTO vessel rupture after a covered stent bailout, epicardial channel perforation management, dissection from collateral tip injection, and more!
Top abstracts of AICT-AsiaPCR 2023
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore the cutting-edge research showcased in the top abstracts of AICT-AsiaPCR 2023, featuring insights on CT-based valve sizing for TAVR in bicuspid aortic stenosis and the impact of bleeding events post-TAVI on long-term mortality.
Learning - Reimagining STEMI network
21 Sep 2023 – From AICT-AsiaPCR 2023
Consult this session to discover the profound impact of initiatives like Stent Saves a Life on patient care, to learn how artificial intelligence is transforming acute myocardial infarction management and to explore the role of pharmaco-invasive strategies and multi-vessel PCI in treating STEMI patients.
Advances in STEMI and Stable CAD
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore cutting-edge insights into STEMI and Stable CAD through these presentations: delve into the intricate details of characterizing culprit coronary lesions in STEMI patients using OCT, uncover the short- and long-term outcomes for Asian STEMI patients following primary PCI and gain a comprehensive understanding of the...
NSTEMI: lessons from real cases
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore real-world cases in this NSTEMI session where experts discuss their experiences in managing challenging scenarios: learn about novel techniques to handle RCA perforations, restore torqued and kinked catheters, and more!
Challenging STEMI cases
22 Sep 2023 – From AICT-AsiaPCR 2023
Dive into complex STEMI cases in this session, featuring presentations on unusual coronary anomalies, the challenges of long diffuse lesions, innovative approaches like intracoronary arterial retrograde thrombolysis, an intriguing case of acute coronary syndrome with uncommon causes, and much more!
Challenges in calcified lesions
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore a variety of challenging cases in this session, from the perplexing uncrossable STEMI to the specialized "Blocked" balloon anchoring technique, the unique challenges of calcified lesions in elderly patients to the debulking of a calcified nodule within the left circumflex ostium through the stent strut,...
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
